3BNC117 and 10-1074 in ART-treated Individuals
An Open Label, Randomized Study of the Safety and Antiretroviral Activity of 3BNC117 and 10-1074 in HIV-infected Individuals on Combination Antiretroviral Therapy and During Analytical Treatment Interruption.
Sponsor: Montefiore Medical Center
This PHASE1 trial investigates Human Immunodeficiency Virus and is currently completed. Montefiore Medical Center leads this study, which shows 14 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Nov 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Nov 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting PHASE1
▶ Show 9 earlier versions
-
Mar 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE1
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE1
Status: Active Not Recruiting → Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE1
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — May 2020 [monthly]
Recruiting PHASE1
-
Jul 2019 — Feb 2020 [monthly]
Recruiting PHASE1
-
Jul 2018 — Jul 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Montefiore Medical Center
- National Institute of Allergy and Infectious Diseases (NIAID)
- Ragon Institute of MGH, MIT and Harvard
- Rockefeller University
For direct contact, visit the study record on ClinicalTrials.gov .